Funding opportunities and RFIs to support research relating to COVID-19 from various agencies/organizations are listed below; please note that this list is not exhaustive. The list will be updated Mondays, Wednesdays, and Fridays by 5 pm. Please contact [email protected] to add a funding opportunity or with any questions.

Proposals for critical continuing laboratory research at Brown that could impact the diagnosis or treatment of COVID-19 in the current crisis should be sent to [email protected] for review and approval.

Title
Agency
Amount
Deadlines
Discipline
Description
Posted Date

NIH
Not specified
5/24/21

Biomedical, Clinical Research, Technology development

Research Area 001: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases; Research Area 002: Development of Therapeutic Products for Biodefense, AntiMicrobial Resistant (AMR) Infections and Emerging Infectious Diseases; Research Area 003: Advanced Development of Sequencing Based Diagnostics for Biothreats and Emerging Infectious Diseases

NIH
Not specified
rolling through 12/15/21

Biomedical, Computation, Public Health

NIGMS will accept the submission of applications for Competitive Revisions to all active NIGMS grants to address only the following research area: Incorporation of data related to SARS-CoV-2 into ongoing research efforts to develop predictive computational models for the spread of SARS-CoV-2 and other related infectious agents.

NIH
Not specified
multiple receipt dates through 5/8/23

Biomedical, Clinical Research, Public Health

Supports research to rapidly expand the knowledge base on acute and long-term neurological and neurocognitive sequelae of COVID-19. New and resubmission applications to address significant questions about the neurological and neurocognitive impacts of COVID-19 infection in aging and the interaction in older adults of COVID-19 with comorbid conditions, including Alzheimer’s disease (AD) and AD-related dementias (ADRD).

Private/Foundations
up to $400,000
3/12/21

Clinical Research

Grants awarded through this RFA will supplement funding from other agencies for ongoing pregnancy cohorts to broaden biospecimen collection and to extend post-natal family tracking. These cohorts and biospecimen collections can be leveraged in future research to understand the effects of gestational infection and inflammation on autism risk in children.

NIH
up to $250,000 direct costs per year over up to 3 years
4/14/21

Public Health, Social Sciences

Supports research grants to address urgent, time-sensitive research questions on the relationships between alcohol consumption and COVID-19 related outcomes and consequences. The principal area of focus is research that can improve public health in the near term by informing responses to the current COVID-19 pandemic, in view of 1) the impact of alcohol misuse on incidence and severity of COVID-19 disease or 2) the effect of the COVID-19 disease and pandemic-induced restrictions on alcohol use and alcohol use disorder (AUD). Also offered as a R03 and R21.

NIH
Not specified
3/31/21

Biomedical, Clinical Research, Public Health, Social Sciences

Supplemental funding for current NCI awardees to stimulate interest and promote studies on the impact of the COVID-19 pandemic on global cancer prevention and control. Apply via PA-20-272.

NIH
Not specified
multiple receipt dates through 9/8/24

Biomedical, Clinical Research, Public Health

Supports research applications focusing on studying the long-term neurocognitive consequences of the COVID-19/HIV/SUDs syndemic. Apply via one of 7 FOAs mentioned in the NOSI.

NIH
Not specified
multiple receipt dates through 9/8/24

Public Health, Clinical Research

Supports research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection. Apply via one of 7 FOAs mentioned in the NOSI.

NIH
Not specified
multiple receipt dates through 5/8/23

Social Sciences, Public Health

Supports projects that will rapidly improve our understanding of the behavioral, social, and economic effects of the pandemic and to enhance our ability to control its spread, particularly as relates to NIH-designated health disparity populations, and other COVID-19 vulnerable groups including older adults. Apply via one of 12 FOAs mentioned in the NOSI.

NIH
Not specified
multiple receipt dates through 11/18/21

Biomedical, Clinical Research, Public Health

Supports research on the impact of COVID-19 as related to diseases and conditions within the NIAMS mission (Rheumatic, Musculoskeletal and Skin Diseases). Apply via PA-20-185, PA-20-195, PAR-21-055, PAR-21-054, or PAR-21-053.

NIH
Not specified
6/5/21, 10/5/21

Social Sciences, Public Health

Solicits community-engaged research to: 1) evaluate intervention strategies (e.g., expand reach, access) to facilitate vaccination (including for COVID-19) uptake in clinical and community contexts; and 2) address the barriers to increasing reach, access, and uptake of vaccinations among health disparity populations at high risk and likely to experience vaccine hesitancy. Apply via PA-20-183 or PA-20-185.

NIH
up to $500,000 per year
6/11/21

Biomedical, Clinical Research, Technology Development

Seeks highly collaborative, multi-disciplinary Program Projects that incorporate understanding of CoV virology and immunology, immunogen design, and innovative vaccine and adjuvant platforms and technologies to discover, design, and develop pan-coronavirus (pan-CoV) vaccine candidates that provide broad protective immunity to multiple CoV strains. Apply via PAR-20-072.

NIH
Not specified
multiple receipt dates through 3/17/21

Biomedical, Clinical Research

To support research on the 2019 novel coronavirus (SARS-CoV-2) and the disease it causes; particularly projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial. Apply via PAR-17-465 (UG3/UH3), PAR-18-462 (U34), PAR-18-332 (U01).

NIH
Not specified
multiple receipt dates through 5/8/23

Clinical Research, Social Sciences, Public Health

Encourages applications in three areas related to the intersection of COVID-19, the associated mitigation actions, and rehabilitation: research to address the rehabilitation needs of survivors of COVID-19; understand the impact of disruptions to rehabilitation services caused by the COVID-19 pandemic and associated mitigation actions; understand the social, behavioral, economic, and health impact of the COVID-19 pandemic and the associated mitigation actions on people with physical disabilities. Apply via PA-20-185 (R01), PA-18-480 (R01), PA-20-200 (R03), or PA-20-194 (R21).

NIH
Not specified
rolling through 7/8/21

Biomedical, Clinical Research

Funding to provide Personal Protective Equipment (PPE) to directly support the needs of the NIAID’s vaccine and treatment clinical trials and clinical studies for COVID-19.

NIH
Not specified
multiple receipt dates through 7/16/23

Biomedical, Clinical Research

Invites applications proposing cutting-edge research on emerging viral infections that are thought to primarily impact non-reproductive sites, at least at initial presentation, but may also affect the male and/or female reproductive tract. Investigate possible effects of emerging viruses on reproductive tissues and cells to better understand potential impacts on fertility that may be sex specific. Apply via PA-20-185 or PA-18-482.

NIH
Not specified
the 14th of each month, through 9/14/21

Biomedical, Clinical Research

Encourages cooperative agreement applications for implementation of investigator-initiated high-risk clinical trials that will augment ongoing and planned clinical trials of therapeutic and vaccine candidates directed against SARS-CoV-2 to evaluate: SARS-CoV-2 candidate vaccines; non-vaccine biomedical prevention of SARS-CoV-2 infection and/or COVID-19; therapeutic approaches to treat COVID-19. Apply via PAR-18-633.

NIH
Not specified
rolling through 7/2/21

Biomedical, Clinical Research

NIAID is allowing the submission of applications for Competitive Revisions to active grants to increase and enhance select research efforts to facilitate the Federal SARS-CoV-2/COVID-19 research response. Areas of interest are limited to: Support to BSL3 facilities actively engaged in the SARS-CoV-2/COVID-19 research response; Generation of critical reagents to support the SARS-CoV-2/COVID-19 research response; Expansion of relevant data systems to expeditiously share SARS-CoV-2/COVID-19 research resources with the broad research community; Expansion of clinical trial infrastructure, or site preparation, for urgent SARS-CoV-2/COVID-19 clinical trial activities. See the NOSI for details; apply via PA-20-135

Private/Foundations
Not specified
Rolling

Clinical Research

CETF is raising funds to grant to applicants, to test the most promising existing drugs in outpatient trials and helping those studies recruit patients

NIH
Diversion of funds with NCI approval
rolling

Biomedical, Clinical Research, Public Health

NCI anticipates that in infrequent cases, NCI-funded investigators will have novel insights and research proposals of immediate relevance to SARS-CoV-2 and COVID-19. In those cases, but only for the duration of the present crisis, NCI would consider requests from its funded grantees and cooperative agreement awardees to engage in limited COVID-19 related research using part of their existing NCI-funded resources.

DoE
Remote Access, in-kind Lab labor; not a monetary grant
rolling

Biomedical, Clinical Research

Oak Ridge National Laboratory (ORNL) is currently restricting site access. Rapid Access proposals will be performed as remote access experiments with limited internal staff. The Department of Energy Basic Energy Sciences advanced neutron sources will provide remote rapid access to advanced user facilities to support research into the COVID-19 virus and the search for effective diagnostics and therapies. Facilities that will be made available at the Spallation Neutron Source (SNS) and High Flux Isotope Reactor (HFIR) at ORNL , include neutron macromolecular crystallography, small-angle scattering, reflectometry, spectroscopy and imaging beamlines.

NIH
Up to $100,000 direct costs per year
4/16/21

Biomedical, Clinical Research, Public Health

Urgent competitive revisions and administrative supplements to existing grants to assess the impact of alcohol as a biological contributor to COVID-19 outcomes, to assess behavioral, social, and economic consequences of the pandemic and to assess the responses that the pandemic has provoked as they relate to alcohol consumption and related outcomes. Apply via PA-18-935 or PA-18-591.

NIH
Not specified
4/15/21

Biomedical, Public Health, Clinical Research

Strengthen the mental health response to COVID-19 and to future public health emergencies; research addressing the intersection of COVID-19, mental health, and HIV treatment and prevention. Apply via PA-18-935 or PA-18-591.

NIH
up to $125,000 in direct costs
5/1/21

Public Health

Impact of the novel Coronavirus pandemic causing COVID-19 disease outbreaks and the resulting disruptions on individual and social wellbeing, health services use, and health outcomes for NIH-designated health disparity populations. Apply via PA-18-935 or PA-18-591.

NIH
Not specified
5/4/21

Biomedical, Public Health

Impact of environmental exposures on COVID-19; the role of environmental exposures in pathogenicity, transmission, individual susceptibility, or prevention and intervention strategies. Apply via PA-20-135.

Private/Foundations
n/a
Rolling

Computation

Access to varied computing capabilities to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections

NIH
Not specified
5/1/21

Biomedical, Public Health

NIA & NIMH are offering Supplements & Revisions to certain active grants. NIA: improve prevention of disease transmission among older adults and mitigation of disease severity and mortality in older adults with COVID-19. NIMH: examine how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or worsening mental health needs and/or suicide risk in midlife and older age adults. Apply via PA-18-935 or PA-18-591.

Private/Foundations
$20 M total in Google Cloud credits
Rolling

Computation

Google is offering Google Cloud credits for researchers to leverage their computing capabilities and infrastructure as they study potential therapies and vaccines, track critical data, and identify new ways to combat COVID-19

NIH
Up to $100,000 direct costs per year
3/31/21

Biomedical, Public Health

Research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders. Apply via PA-18-935 or PA-18-591.

DoD
Not specified
Rolling

Biomedical, Clinical Research, Technology development

The U.S. government is providing a portal for the 2019 novel coronavirus (COVID-19) medical countermeasures task force as a single point of entry for the submission of ideas and information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak.

DoD
Not specified
Rolling

Technology development, Biomedical, Engineering

The DARPA technical offices that are focused on COVID-19 efforts are the Defense Sciences Office (DSO) and the Biological Technology Office (BTO), both of which have Office-Wide Broad Agency Announcements (BAA) that are open for the submission of new ideas at any time.

Private/Foundations
n/a
Rolling

Computation, Physical Sciences

Announcing the availability of COVID-19 datasets; new text and data mining techniques sought to help the science community use COVID-19 research data

DoD
Not specified
White papers due by 10/31/21

Biomedical, Devices

Diagnostic assays, COVID-19 Vaccine, COVID-19 Therapeutics, Immunomodulators or therapeutics targeting lung repair, Pre-exposure and post-exposure prophylaxis, Respiratory protective devices, Ventilators, Advanced Manufacturing Technologies